These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 26297223)

  • 41. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
    Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The significance of detection of serum miR-423-5p and miR-484 for diagnosis of colorectal cancer.
    Lu X; Lu J
    Clin Lab; 2015; 61(1-2):187-90. PubMed ID: 25807655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients.
    Wanram S; Klaewkla N; Pinyosri P
    Microrna; 2024; 13(1):56-62. PubMed ID: 38231064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the Plasma Expression Levels of miR-21 and miR-145 as Potential Non-Invasive Biomarkers for Early Detection of Colorectal Cancer.
    Rattan Negi R; Rana SV; Gupta V; Gupta R; Dhawan DK
    Asian Pac J Cancer Prev; 2024 Aug; 25(8):2797-2804. PubMed ID: 39205577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.
    Chen Y; Chen J; Liu Y; Li S; Huang P
    Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer].
    Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770
    [No Abstract]   [Full Text] [Related]  

  • 50. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.
    Zheng G; Du L; Yang X; Zhang X; Wang L; Yang Y; Li J; Wang C
    Br J Cancer; 2014 Nov; 111(10):1985-92. PubMed ID: 25233400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
    Xu L; Li M; Wang M; Yan D; Feng G; An G
    BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
    Wang DS; Zhong B; Zhang MS; Gao Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.
    Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
    Yuan D; Li K; Zhu K; Yan R; Dang C
    Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
    Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
    Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer.
    Wang YG; He Q; Guo SQ; Shi ZZ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8345-8353. PubMed ID: 31646564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.